Bindu Pharmaceuticals

Hyderabad, India Founded: 2009 • Age: 17 yrs
Produces high-quality pharmaceutical products, including tablets, capsules, pellets, and granules.

About Bindu Pharmaceuticals

Bindu Pharmaceuticals is a Healthcare company based in Hyderabad (India) founded in 2009. It produces high-quality pharmaceutical products, including tablets, capsules, pellets, and granules. It operates on a B2B model. Its Indian entity Integrin Healthcare Private Limited reported revenue of β‚Ή9.54 Cr. Its focus areas include Healthcare and Pharmaceuticals, Pharmaceuticals, Drug Manufacturing and Formulation and Production. Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.

Company details

Bindu Pharmaceuticals produces high-quality pharmaceutical products, including tablets, capsules, pellets, and granules through healthcare and pharmaceuticals, producing pharmaceutical products, drug manufacturing, and formulation and production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Key Metrics
  • Annual Revenue
    ₹9.54 Cr

    FY 2025 · +105% YoY

  • Net Profit
    ₹2.08 Cr

    FY 2025 · 22% margin

  • EBITDA
    ₹2.12 Cr

    FY 2025 · 22% margin

Board of directors of Integrin Healthcare Private Limited (Bindu Pharmaceuticals)

Integrin Healthcare Private Limited is the primary company behind Bindu Pharmaceuticals. The board of Integrin Healthcare Private Limited currently have 3 directors; the longest-serving is Srinivas Rao Marikanti, appointed in 2020. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Srinivas Rao Marikanti
DIN 02890494
Director21 Oct 20206 yrsIntegrin Healthcare Private Limited
Dhana Laxmi Marikanti
DIN 05224617
Director22 Jul 20215 yrs 3 moIntegrin Healthcare Private Limited
Sreedhar Tirumala
DIN 07153446
Director22 Jan 20242 yrs 9 moIntegrin Healthcare Private Limited

Financials of Bindu Pharmaceuticals

Figures of Integrin Healthcare Private Limited, the primary company behind Bindu Pharmaceuticals, for FY 2025. Revenue was ₹9.54 Cr (+105% year on year). Net profit was ₹2.08 Cr (22% margin). EBITDA was ₹2.12 Cr (22% margin). Revenue has grown at a compounded annual rate of +117% over three years and +181% over five years.

  • ₹9.54 CrRevenue · FY 2025 · +105% YoY
  • ₹2.08 CrNet profit · 22% margin
  • ₹2.12 CrEBITDA · 22% margin
  • ₹92.8 LakhPaid-up capital
  • +117%Revenue CAGR, 3 years
  • +181%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Integrin Healthcare Private Limited are on its company page.

Premium access

Detailed financial statements for Bindu Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Bindu Pharmaceuticals

Bindu Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
inventiahealthcare.com1985Mumbai, India$42.49M980
Oral solid drug delivery systems are manufactured and developed.
zimlab.in1989Nagpur, India$8.2M598
Solid and semisolid dosage forms are developed and manufactured.
halewoodlabs.com1984Ahmedabad, India348
Provides contract manufacturing services for food, pharmaceuticals, and related products globally.
Premium access

Detailed competitors of Bindu Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bindu Pharmaceuticals

Bindu Pharmaceuticals was founded in 2009.

Bindu Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

The primary company behind Bindu Pharmaceuticals, Integrin Healthcare Private Limited, reported revenue of β‚Ή9.54 Cr for FY 2025, up 105% year on year.

Bindu Pharmaceuticals produces high-quality pharmaceutical products, including tablets, capsules, pellets, and granules through healthcare and pharmaceuticals, producing pharmaceutical products, drug manufacturing, and formulation and production. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.

Bindu Pharmaceuticals's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.

Bindu Pharmaceuticals operates through Integrin Healthcare Private Limited.

The legal entities of Bindu Pharmaceuticals currently have 3 directors, including Dhana Laxmi Marikanti, Sreedhar Tirumala, Srinivas Rao Marikanti.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available